{
    "2018-04-04": [
        [
            {
                "time": "",
                "original_text": "[买入评级]凯莱英(002821)年报点评：业绩增长稳健 构建药物一体化服务生态圈",
                "features": {
                    "keywords": [
                        "凯莱英",
                        "年报",
                        "业绩增长",
                        "稳健",
                        "药物一体化",
                        "服务生态圈"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[推荐评级]医药生物行业2018年二季度策略报告：把握政策利好 聚焦创新和龙头",
                "features": {
                    "keywords": [
                        "医药生物",
                        "行业",
                        "政策利好",
                        "创新",
                        "龙头"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[强于大市评级]生物医药行业月报：中小创优先!医药板块发动春季攻势",
                "features": {
                    "keywords": [
                        "生物医药",
                        "行业",
                        "中小创",
                        "春季攻势",
                        "医药板块"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "凯莱英2017年报点评:业绩增长迅速,海内外齐头并进",
                "features": {
                    "keywords": [
                        "凯莱英",
                        "2017年报",
                        "业绩增长",
                        "迅速",
                        "海内外",
                        "齐头并进"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}